Bone Morphogenetic Protein (BMP) 2 Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Bone Morphogenetic Protein (BMP) 2 market size was valued at USD 512.5 million in 2022 and is forecast to a readjusted size of USD 684.1 million by 2029 with a CAGR of 4.2% during review period.

Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.

According to types, the most proportion of the Bone Morphogenetic Protein (BMP) 2 is Sponge, taking almost 99% sales share of global market in 2020. The most proportion of Bone Morphogenetic Protein (BMP) 2 is used for Spinal Fusion and the proportion is about 66% in 2020. Global market of BMP 2 is extremely intensive. Medtronic, Jiuyuan Gene Engineering and Cellumed are the only 3 companies supplying this product. Furthermore, among these companies, Medtronic takes almost 95% share of global market.

This report is a detailed and comprehensive analysis for global Bone Morphogenetic Protein (BMP) 2 market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Bone Morphogenetic Protein (BMP) 2 market size and forecasts, in consumption value ($ Million), 2018-2029
Global Bone Morphogenetic Protein (BMP) 2 market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Bone Morphogenetic Protein (BMP) 2 market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Bone Morphogenetic Protein (BMP) 2 market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bone Morphogenetic Protein (BMP) 2
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Bone Morphogenetic Protein (BMP) 2 market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Medtronic
   Jiuyuan Gene Engineering
   Cellumed

   Sponge
   Gel

   Spinal Fusion
   Trauma Surgery
   Oral Maxillofacial Surgery
   Reconstructive Surgery

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the BMP-2 market in 2025?

The BMP-2 market in 2025 will benefit from strong advancements in regenerative medicine, particularly in orthopedics. Its ability to enhance bone healing, reduce complications in surgeries, and its growing acceptance in spinal fusion procedures will strengthen its market position. The increasing number of surgical procedures worldwide will also contribute to its demand.

What are the weaknesses of the BMP-2 market in 2025?

Despite its benefits, the BMP-2 market may face challenges such as high production costs, which could limit affordability and accessibility. There are also concerns over potential side effects like ectopic bone formation, which might restrict its broader application. Limited clinical data in some areas may further inhibit its growth.

What opportunities exist for the BMP-2 market in 2025?

There is significant potential for expansion in emerging markets where orthopedic procedures are becoming more common due to an aging population and rising healthcare access. Additionally, the development of BMP-2 in combination with other regenerative therapies and in broader applications like dental implants or fracture healing presents exciting growth opportunities.

What threats might affect the BMP-2 market in 2025?

The BMP-2 market could face threats from competitive bone regeneration products, such as stem cell-based therapies or alternative growth factors. Regulatory challenges and concerns over long-term safety could lead to stricter approval processes, potentially hindering market growth. Additionally, the high cost of treatment could lead to reimbursement issues in certain regions.

What are the political factors affecting the BMP-2 market in 2025?

Political factors such as healthcare policies and regulatory frameworks will play a significant role in shaping the BMP-2 market. Governments' focus on improving healthcare infrastructure and their willingness to fund advanced treatments may boost market growth. However, changing regulations regarding medical device approvals and reimbursement policies could present challenges.

How do economic factors impact the BMP-2 market in 2025?

Economic factors like healthcare spending, the cost of treatment, and the affordability of BMP-2 therapies will impact market growth. In regions with limited healthcare budgets, the high cost of BMP-2 products could hinder their adoption. On the other hand, rising disposable incomes in emerging markets could create new opportunities for growth.

What social factors influence the BMP-2 market in 2025?

Social factors such as an aging population and increasing awareness about bone-related diseases are key drivers for the BMP-2 market. As more people undergo orthopedic surgeries, the demand for treatments like BMP-2 will rise. Additionally, the growing emphasis on quality of life and faster recovery times will encourage the adoption of BMP-2 in clinical practices.

What technological factors affect the BMP-2 market in 2025?

Technological advancements in regenerative medicine, biotechnology, and surgical techniques are crucial for the growth of the BMP-2 market. New delivery methods, improved formulations, and enhanced safety profiles could expand BMP-2's applications in diverse medical fields. Continuous innovation will allow for more precise and effective treatments, driving market growth.

What environmental factors could impact the BMP-2 market in 2025?

Environmental factors, such as sustainability concerns related to manufacturing processes and the sourcing of raw materials, may affect the BMP-2 market. Companies will need to focus on minimizing environmental impact through eco-friendly production methods to meet regulatory requirements and societal expectations for sustainable practices.

What legal factors influence the BMP-2 market in 2025?

Legal factors, including patent laws, intellectual property protection, and product liability regulations, will significantly influence the BMP-2 market. Any legal disputes over patent rights or safety concerns could disrupt market dynamics. Additionally, stricter regulatory requirements for clinical trials and product approvals could delay time-to-market for BMP-2 products.

What are the suppliers in the BMP-2 market in 2025?

Suppliers in the BMP-2 market include biotechnology companies, pharmaceutical manufacturers, raw material suppliers, and research institutions. These suppliers provide the necessary bioengineered proteins, production equipment, and scientific expertise needed to develop and manufacture BMP-2 products.

Who are the customers of the BMP-2 market in 2025?

The primary customers of the BMP-2 market are healthcare providers, including hospitals, orthopedic surgeons, and clinics, as well as patients requiring treatments for bone repair and regeneration. Additionally, patients undergoing spinal fusion surgeries and those with severe bone fractures are key end-users of BMP-2 products.

What are the inputs required in the BMP-2 market in 2025?

The inputs required in the BMP-2 market include high-quality raw materials like recombinant proteins, research and clinical data, manufacturing technologies, regulatory approvals, and skilled labor for production. Additionally, innovation in drug delivery systems and advanced formulations plays a crucial role in the development process.

What are the processes involved in the BMP-2 market in 2025?

Processes involved in the BMP-2 market include research and development (R&D) for new formulations, clinical trials to test safety and efficacy, regulatory approvals, manufacturing, distribution, and post-market surveillance. Continuous product innovation, quality control, and meeting safety standards are essential to the market's success.

What are the outputs of the BMP-2 market in 2025?

The primary outputs of the BMP-2 market are the various BMP-2 formulations used in medical treatments, including bone regeneration products, surgical implants, and biologics. These products aim to enhance bone healing, improve recovery times, and reduce complications in surgeries. Additionally, ongoing research results and post-market data contribute to improving the market's offerings.

What is the threat of new entrants in the BMP-2 market in 2025?

The threat of new entrants is moderate. While the BMP-2 market offers growth potential, high barriers to entry such as the need for significant investment in R&D, regulatory approvals, and specialized manufacturing processes make it difficult for new players to quickly enter the market. Established companies with strong intellectual property and distribution networks dominate the space.

How strong is the bargaining power of suppliers in the BMP-2 market in 2025?

The bargaining power of suppliers is moderate to high. Suppliers of raw materials, particularly recombinant proteins, play a critical role in the production of BMP-2 products. As specialized materials and advanced technologies are required, suppliers with a unique or dominant position in these resources can influence pricing and availability, which impacts the overall market.

What is the bargaining power of buyers in the BMP-2 market in 2025?

The bargaining power of buyers is moderate. Healthcare providers, such as hospitals and clinics, are the primary buyers of BMP-2 products. While the demand for BMP-2 is driven by the growing need for orthopedic treatments, healthcare providers have limited alternatives due to the unique advantages of BMP-2. However, as more alternatives enter the market, buyer power could increase.

How intense is the threat of substitute products in the BMP-2 market in 2025?

The threat of substitutes is moderate. Although BMP-2 is effective for bone healing and regeneration, alternative treatments like stem cell therapy, growth factors, and synthetic biomaterials are emerging as potential substitutes. However, BMP-2's proven clinical efficacy and FDA approval give it a competitive edge, which limits the threat of substitutes for the time being.

How intense is the competitive rivalry in the BMP-2 market in 2025?

Competitive rivalry is high in the BMP-2 market. Several established companies, including biopharma and medtech firms, are competing to capture market share. Companies are engaged in constant innovation, focusing on improving the safety, effectiveness, and cost-efficiency of BMP-2 products. This intensifies competition, especially with the entry of newer alternatives to BMP-2.

What are the key raw materials required in the BMP-2 market in 2025?

The key raw materials required for BMP-2 production include recombinant proteins, growth factors, and biomaterials for delivery systems. These materials are essential for the formulation and production of the BMP-2 product, ensuring it is effective for bone regeneration and healing.

Who are the main suppliers in the BMP-2 market in 2025?

Main suppliers in the BMP-2 market include biotechnology companies, pharmaceutical manufacturers, and specialized suppliers of recombinant proteins and growth factors. These suppliers provide the raw materials and technology required to manufacture high-quality BMP-2 products that meet regulatory and clinical standards.

What are the technological advancements impacting the BMP-2 market in 2025?

Technological advancements in genetic engineering, protein synthesis, and drug delivery systems are significantly impacting the BMP-2 market. Innovations in more efficient recombinant protein production methods, as well as advancements in controlled release and targeted delivery systems, are improving the effectiveness and safety of BMP-2 therapies.

How do regulatory factors influence the upstream process in the BMP-2 market in 2025?

Regulatory factors play a critical role in the upstream process of the BMP-2 market. The need for stringent regulatory approvals, particularly from the FDA and EMA, influences the production and supply chain. Compliance with these regulations ensures safety, quality, and efficacy of the products, which can drive up production costs and lengthen development timelines.

What are the challenges faced by upstream suppliers in the BMP-2 market in 2025?

Upstream suppliers face challenges such as maintaining the consistency and quality of recombinant proteins, navigating complex regulatory environments, and managing the high costs associated with producing biologically active proteins. Additionally, the limited number of suppliers capable of providing specialized raw materials may create supply chain bottlenecks or price fluctuations.

What are the key processes involved in the midstream stage of the BMP-2 market in 2025?

The key processes in the midstream stage of the BMP-2 market include manufacturing, quality control, and packaging. After the raw materials are sourced, the production process involves the biotechnological synthesis of BMP-2 proteins, followed by purification, testing for efficacy and safety, and final packaging for distribution.

How does the manufacturing process impact the BMP-2 market in 2025?

The manufacturing process is crucial in the BMP-2 market as it directly affects product quality, consistency, and scalability. The complexity of producing biologically active proteins and ensuring stringent compliance with regulatory standards can drive up production costs. Innovations in manufacturing technologies, such as recombinant DNA technology, help to streamline processes and improve efficiency.

What are the distribution challenges faced by the BMP-2 market in 2025?

Distribution challenges in the BMP-2 market include ensuring timely delivery to healthcare providers, managing cold chain logistics for temperature-sensitive products, and navigating regulatory barriers in different regions. Furthermore, reaching emerging markets where healthcare infrastructure is less developed can be difficult and costly.

How do regulatory and compliance factors influence the midstream process in the BMP-2 market?

Regulatory and compliance factors have a significant influence on the midstream process. Manufacturers must adhere to strict regulatory standards for safety, quality, and efficacy set by agencies such as the FDA and EMA. These regulations can impact production timelines, costs, and require extensive documentation, which can sometimes delay the availability of BMP-2 products in the market.

What technological innovations are shaping the midstream process in the BMP-2 market?

Technological innovations such as automation in production, improvements in protein expression systems, and advances in bioreactor design are shaping the midstream process. These innovations help to reduce manufacturing costs, improve product yield, and ensure more consistent product quality, thus enhancing the overall efficiency of the BMP-2 production and distribution processes.

What are the key activities in the downstream stage of the BMP-2 market in 2025?

The key activities in the downstream stage of the BMP-2 market include marketing, sales, distribution, and post-market surveillance. These activities focus on ensuring the product reaches healthcare providers, ensuring patient safety, and monitoring long-term outcomes to ensure the product's effectiveness and safety.

How does the sales and marketing process impact the BMP-2 market in 2025?

Sales and marketing efforts are critical in raising awareness among healthcare providers about the benefits and applications of BMP-2 products. Effective marketing strategies that highlight the product’s safety, efficacy, and cost-effectiveness can drive adoption. However, competition from alternative therapies may challenge these efforts, requiring strong differentiation and evidence-based marketing.

What role does distribution play in the BMP-2 market in 2025?

Distribution plays a vital role in ensuring that BMP-2 products reach healthcare providers in a timely manner. This includes managing logistics for both developed and emerging markets, addressing potential supply chain disruptions, and ensuring compliance with regulatory requirements for each region. Efficient distribution ensures product availability where demand is high.

What challenges are faced by the downstream players in the BMP-2 market?

Downstream players face challenges such as ensuring proper reimbursement structures, educating healthcare professionals about BMP-2's benefits, and managing competition from alternative treatments. Additionally, price sensitivity in some markets and logistical hurdles, especially in emerging economies, can hinder market penetration and growth.

How does post-market surveillance affect the BMP-2 market in 2025?

Post-market surveillance is crucial to monitor the long-term safety and effectiveness of BMP-2 products. It ensures any adverse effects or complications are quickly identified and addressed. Ongoing monitoring also helps in refining treatment protocols and contributing to the body of clinical evidence, which is essential for maintaining product trust and regulatory compliance.

Chapter 1, to describe Bone Morphogenetic Protein (BMP) 2 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Bone Morphogenetic Protein (BMP) 2, with revenue, gross margin and global market share of Bone Morphogenetic Protein (BMP) 2 from 2018 to 2023.
Chapter 3, the Bone Morphogenetic Protein (BMP) 2 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Bone Morphogenetic Protein (BMP) 2 market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Bone Morphogenetic Protein (BMP) 2.
Chapter 13, to describe Bone Morphogenetic Protein (BMP) 2 research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Bone Morphogenetic Protein (BMP) 2
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of Bone Morphogenetic Protein (BMP) 2 by Type
       1.3.1 Overview: Global Bone Morphogenetic Protein (BMP) 2 Market Size by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Global Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Type in 2022
       1.3.3 Sponge
       1.3.4 Gel
   1.4 Global Bone Morphogenetic Protein (BMP) 2 Market by Application
       1.4.1 Overview: Global Bone Morphogenetic Protein (BMP) 2 Market Size by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Spinal Fusion
       1.4.3 Trauma Surgery
       1.4.4 Oral Maxillofacial Surgery
       1.4.5 Reconstructive Surgery
   1.5 Global Bone Morphogenetic Protein (BMP) 2 Market Size & Forecast
   1.6 Global Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast by Region
       1.6.1 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global Bone Morphogenetic Protein (BMP) 2 Market Size by Region, (2018-2029)
       1.6.3 North America Bone Morphogenetic Protein (BMP) 2 Market Size and Prospect (2018-2029)
       1.6.4 Europe Bone Morphogenetic Protein (BMP) 2 Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size and Prospect (2018-2029)
       1.6.6 South America Bone Morphogenetic Protein (BMP) 2 Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa Bone Morphogenetic Protein (BMP) 2 Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 Medtronic
       2.1.1 Medtronic Details
       2.1.2 Medtronic Major Business
       2.1.3 Medtronic Bone Morphogenetic Protein (BMP) 2 Product and Solutions
       2.1.4 Medtronic Bone Morphogenetic Protein (BMP) 2 Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Medtronic Recent Developments and Future Plans
   2.2 Jiuyuan Gene Engineering
       2.2.1 Jiuyuan Gene Engineering Details
       2.2.2 Jiuyuan Gene Engineering Major Business
       2.2.3 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Product and Solutions
       2.2.4 Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Jiuyuan Gene Engineering Recent Developments and Future Plans
   2.3 Cellumed
       2.3.1 Cellumed Details
       2.3.2 Cellumed Major Business
       2.3.3 Cellumed Bone Morphogenetic Protein (BMP) 2 Product and Solutions
       2.3.4 Cellumed Bone Morphogenetic Protein (BMP) 2 Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Cellumed Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global Bone Morphogenetic Protein (BMP) 2 Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of Bone Morphogenetic Protein (BMP) 2 by Company Revenue
       3.2.2 Top 3 Bone Morphogenetic Protein (BMP) 2 Players Market Share in 2022
       3.2.3 Top 6 Bone Morphogenetic Protein (BMP) 2 Players Market Share in 2022
   3.3 Bone Morphogenetic Protein (BMP) 2 Market: Overall Company Footprint Analysis
       3.3.1 Bone Morphogenetic Protein (BMP) 2 Market: Region Footprint
       3.3.2 Bone Morphogenetic Protein (BMP) 2 Market: Company Product Type Footprint
       3.3.3 Bone Morphogenetic Protein (BMP) 2 Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

   4.1 Global Bone Morphogenetic Protein (BMP) 2 Consumption Value and Market Share by Type (2018-2023)
   4.2 Global Bone Morphogenetic Protein (BMP) 2 Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

   5.1 Global Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Application (2018-2023)
   5.2 Global Bone Morphogenetic Protein (BMP) 2 Market Forecast by Application (2024-2029)

6 North America

   6.1 North America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2018-2029)
   6.2 North America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2018-2029)
   6.3 North America Bone Morphogenetic Protein (BMP) 2 Market Size by Country
       6.3.1 North America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2018-2029)
       6.3.2 United States Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       6.3.3 Canada Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       6.3.4 Mexico Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2018-2029)
   7.2 Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2018-2029)
   7.3 Europe Bone Morphogenetic Protein (BMP) 2 Market Size by Country
       7.3.1 Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2018-2029)
       7.3.2 Germany Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       7.3.3 France Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       7.3.5 Russia Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       7.3.6 Italy Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2018-2029)
   8.2 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2018-2029)
   8.3 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Market Size by Region
       8.3.1 Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value by Region (2018-2029)
       8.3.2 China Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       8.3.3 Japan Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       8.3.4 South Korea Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       8.3.5 India Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       8.3.7 Australia Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)

9 South America

   9.1 South America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2018-2029)
   9.2 South America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2018-2029)
   9.3 South America Bone Morphogenetic Protein (BMP) 2 Market Size by Country
       9.3.1 South America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2018-2029)
       9.3.2 Brazil Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       9.3.3 Argentina Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2018-2029)
   10.2 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2018-2029)
   10.3 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Market Size by Country
       10.3.1 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2018-2029)
       10.3.2 Turkey Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)
       10.3.4 UAE Bone Morphogenetic Protein (BMP) 2 Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 Bone Morphogenetic Protein (BMP) 2 Market Drivers
   11.2 Bone Morphogenetic Protein (BMP) 2 Market Restraints
   11.3 Bone Morphogenetic Protein (BMP) 2 Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 Bone Morphogenetic Protein (BMP) 2 Industry Chain
   12.2 Bone Morphogenetic Protein (BMP) 2 Upstream Analysis
   12.3 Bone Morphogenetic Protein (BMP) 2 Midstream Analysis
   12.4 Bone Morphogenetic Protein (BMP) 2 Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer

List of Tables

   Table 1. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. Medtronic Company Information, Head Office, and Major Competitors
   Table 6. Medtronic Major Business
   Table 7. Medtronic Bone Morphogenetic Protein (BMP) 2 Product and Solutions
   Table 8. Medtronic Bone Morphogenetic Protein (BMP) 2 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. Medtronic Recent Developments and Future Plans
   Table 10. Jiuyuan Gene Engineering Company Information, Head Office, and Major Competitors
   Table 11. Jiuyuan Gene Engineering Major Business
   Table 12. Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Product and Solutions
   Table 13. Jiuyuan Gene Engineering Bone Morphogenetic Protein (BMP) 2 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. Jiuyuan Gene Engineering Recent Developments and Future Plans
   Table 15. Cellumed Company Information, Head Office, and Major Competitors
   Table 16. Cellumed Major Business
   Table 17. Cellumed Bone Morphogenetic Protein (BMP) 2 Product and Solutions
   Table 18. Cellumed Bone Morphogenetic Protein (BMP) 2 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. Cellumed Recent Developments and Future Plans
   Table 20. Global Bone Morphogenetic Protein (BMP) 2 Revenue (USD Million) by Players (2018-2023)
   Table 21. Global Bone Morphogenetic Protein (BMP) 2 Revenue Share by Players (2018-2023)
   Table 22. Breakdown of Bone Morphogenetic Protein (BMP) 2 by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 23. Market Position of Players in Bone Morphogenetic Protein (BMP) 2, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 24. Head Office of Key Bone Morphogenetic Protein (BMP) 2 Players
   Table 25. Bone Morphogenetic Protein (BMP) 2 Market: Company Product Type Footprint
   Table 26. Bone Morphogenetic Protein (BMP) 2 Market: Company Product Application Footprint
   Table 27. Bone Morphogenetic Protein (BMP) 2 New Market Entrants and Barriers to Market Entry
   Table 28. Bone Morphogenetic Protein (BMP) 2 Mergers, Acquisition, Agreements, and Collaborations
   Table 29. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value (USD Million) by Type (2018-2023)
   Table 30. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value Share by Type (2018-2023)
   Table 31. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value Forecast by Type (2024-2029)
   Table 32. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2018-2023)
   Table 33. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value Forecast by Application (2024-2029)
   Table 34. North America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2018-2023) & (USD Million)
   Table 35. North America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2024-2029) & (USD Million)
   Table 36. North America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2018-2023) & (USD Million)
   Table 37. North America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2024-2029) & (USD Million)
   Table 38. North America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2018-2023) & (USD Million)
   Table 39. North America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2024-2029) & (USD Million)
   Table 40. Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2018-2023) & (USD Million)
   Table 41. Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2024-2029) & (USD Million)
   Table 42. Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2018-2023) & (USD Million)
   Table 43. Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2024-2029) & (USD Million)
   Table 44. Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2018-2023) & (USD Million)
   Table 45. Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2024-2029) & (USD Million)
   Table 46. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2018-2023) & (USD Million)
   Table 47. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2024-2029) & (USD Million)
   Table 48. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2018-2023) & (USD Million)
   Table 49. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2024-2029) & (USD Million)
   Table 50. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value by Region (2018-2023) & (USD Million)
   Table 51. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value by Region (2024-2029) & (USD Million)
   Table 52. South America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2018-2023) & (USD Million)
   Table 53. South America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2024-2029) & (USD Million)
   Table 54. South America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2018-2023) & (USD Million)
   Table 55. South America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2024-2029) & (USD Million)
   Table 56. South America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2018-2023) & (USD Million)
   Table 57. South America Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2024-2029) & (USD Million)
   Table 58. Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2018-2023) & (USD Million)
   Table 59. Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type (2024-2029) & (USD Million)
   Table 60. Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2018-2023) & (USD Million)
   Table 61. Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value by Application (2024-2029) & (USD Million)
   Table 62. Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2018-2023) & (USD Million)
   Table 63. Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value by Country (2024-2029) & (USD Million)
   Table 64. Bone Morphogenetic Protein (BMP) 2 Raw Material
   Table 65. Key Suppliers of Bone Morphogenetic Protein (BMP) 2 Raw Materials

List of Figures

   Figure 1. Bone Morphogenetic Protein (BMP) 2 Picture
   Figure 2. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Type in 2022
   Figure 4. Sponge
   Figure 5. Gel
   Figure 6. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 7. Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Application in 2022
   Figure 8. Spinal Fusion Picture
   Figure 9. Trauma Surgery Picture
   Figure 10. Oral Maxillofacial Surgery Picture
   Figure 11. Reconstructive Surgery Picture
   Figure 12. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 13. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 14. Global Market Bone Morphogenetic Protein (BMP) 2 Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 15. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Region (2018-2029)
   Figure 16. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Region in 2022
   Figure 17. North America Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 18. Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 19. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 20. South America Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 21. Middle East and Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 22. Global Bone Morphogenetic Protein (BMP) 2 Revenue Share by Players in 2022
   Figure 23. Bone Morphogenetic Protein (BMP) 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 24. Global Top 3 Players Bone Morphogenetic Protein (BMP) 2 Market Share in 2022
   Figure 25. Global Top 6 Players Bone Morphogenetic Protein (BMP) 2 Market Share in 2022
   Figure 26. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value Share by Type (2018-2023)
   Figure 27. Global Bone Morphogenetic Protein (BMP) 2 Market Share Forecast by Type (2024-2029)
   Figure 28. Global Bone Morphogenetic Protein (BMP) 2 Consumption Value Share by Application (2018-2023)
   Figure 29. Global Bone Morphogenetic Protein (BMP) 2 Market Share Forecast by Application (2024-2029)
   Figure 30. North America Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Type (2018-2029)
   Figure 31. North America Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Application (2018-2029)
   Figure 32. North America Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Country (2018-2029)
   Figure 33. United States Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 34. Canada Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 35. Mexico Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 36. Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Type (2018-2029)
   Figure 37. Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Application (2018-2029)
   Figure 38. Europe Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Country (2018-2029)
   Figure 39. Germany Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 40. France Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 41. United Kingdom Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 42. Russia Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 43. Italy Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 44. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Type (2018-2029)
   Figure 45. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Application (2018-2029)
   Figure 46. Asia-Pacific Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Region (2018-2029)
   Figure 47. China Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 48. Japan Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 49. South Korea Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 50. India Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 51. Southeast Asia Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 52. Australia Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 53. South America Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Type (2018-2029)
   Figure 54. South America Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Application (2018-2029)
   Figure 55. South America Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Country (2018-2029)
   Figure 56. Brazil Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 57. Argentina Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 58. Middle East and Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Type (2018-2029)
   Figure 59. Middle East and Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Application (2018-2029)
   Figure 60. Middle East and Africa Bone Morphogenetic Protein (BMP) 2 Consumption Value Market Share by Country (2018-2029)
   Figure 61. Turkey Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 62. Saudi Arabia Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 63. UAE Bone Morphogenetic Protein (BMP) 2 Consumption Value (2018-2029) & (USD Million)
   Figure 64. Bone Morphogenetic Protein (BMP) 2 Market Drivers
   Figure 65. Bone Morphogenetic Protein (BMP) 2 Market Restraints
   Figure 66. Bone Morphogenetic Protein (BMP) 2 Market Trends
   Figure 67. Porters Five Forces Analysis
   Figure 68. Manufacturing Cost Structure Analysis of Bone Morphogenetic Protein (BMP) 2 in 2022
   Figure 69. Manufacturing Process Analysis of Bone Morphogenetic Protein (BMP) 2
   Figure 70. Bone Morphogenetic Protein (BMP) 2 Industrial Chain
   Figure 71. Methodology
   Figure 72. Research Process and Data Source